{"news_desk": "Business", "print_page": "2", "section_name": "Business Day", "subsection_name": null, "document_type": "article", "multimedia": [], "abstract": "AbbVie reports its all-pill hepatitis C combo treatment has been approved for patients in the 28 European Union member countries.", "type_of_material": "Brief", "word_count": "61", "lead_paragraph": "The drug maker AbbVie said that its new, all-pill hepatitis C combo treatment had been approved for patients in the 28 European Union member countries.", "pub_date": "2015-01-20T00:00:00Z", "_id": "54bdb81c38f0d807ab72dd90", "byline": {"contributor": "", "original": "By THE ASSOCIATED PRESS", "person": [], "organization": "THE ASSOCIATED PRESS"}, "source": "The New York Times", "snippet": "The drug maker AbbVie said that its new, all-pill hepatitis C combo treatment had been approved for patients in the 28 European Union member countries.", "web_url": "http://www.nytimes.com/2015/01/20/business/european-union-approves-hepatitis-c-treatment.html", "slideshow_credits": null, "blog": [], "keywords": [{"rank": "1", "is_major": "Y", "value": "Hepatitis", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "AbbVie Inc", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "European Union", "name": "organizations"}], "headline": {"main": "European Union Approves Hepatitis C Treatment ", "content_kicker": "Business Briefing", "print_headline": "European Union Approves Hepatitis C Treatment"}}